Goldline Pharmaceutical
add_icon

Goldline Pharmaceutical

39.00
-0.25
(-0.64%)
Market Cap
37.46 Cr
PE Ratio
-
Volume
18,000.00
Day High - Low
40.00 - 39.00
52W High-Low
60.00 - 33.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
37.46 Cr
EPS
5.97
PE Ratio
-
PB Ratio
1.87
Book Value
21.00
EBITDA
6.94
Dividend Yield
0.00 %
Industry
-
Sector
-
Return on Equity
27.37
Debt to Equity
1.22
Forecast For
Actual

Company News

View All News
Caret
neutral
Goldline Pharmaceutical Ltd has appointed M/s. Avinash Gandhewar & Associates as Secretarial Auditor for FY2025-26. The firm will conduct the audit for the financial year ending March 31, 2026.
positive
Swapan Khandelwal bought 60,000 shares, increasing holding to 29.27%.
positive
Goldline Pharmaceutical Limited reported a 45.2% rise in net profit to ₹411.71 lakh for FY26. Revenue from operations increased 11.2% to ₹3,119.76 lakh.
View more
Growth Rate
Revenue Growth
11.03 %
Net Income Growth
41.43 %
Cash Flow Change
-20.55 %
ROE
19.21 %
ROCE
18.67 %
EBITDA Margin (Avg.)
6.97 %

Yearly Financial Results

Annual Financials
2023
2024
2025
2026
Revenue
20
24
28
31
Expenses
18
19
22
24
EBITDA
2
4
6
7
Operating Profit %
11 %
18 %
21 %
22 %
Depreciation
0
0
0
0
Interest
2
2
2
1
Profit Before Tax
0
3
4
5
Tax
0
1
1
1
Net Profit
0
2
3
4
EPS in ₹
0.43
3.01
4.11
5.97

Balance Sheet

Balance Sheet
2023
2024
2025
2026
Total Assets
19
23
26
29
Fixed Assets
3
3
3
3
Current Assets
17
20
23
26
Capital Work in Progress
0
0
0
0
Investments
0
0
0
6
Other Assets
17
20
23
0
Total Equity & Liabilities
19
23
26
29
Current Liabilities
9
10
12
12
Non Current Liabilities
5
5
4
3
Total Equity
6
8
10
14
Reserve & Surplus
2
4
2
6
Share Capital
4
4
9
9

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
-0
1
0
Investing Activities
-1
-1
0
Operating Activities
2
3
2
Financing Activities
-1
-1
-2

Share Holding

% Holding
Sept 2025
May 2026
Promoter
79.71 %
79.71 %
FIIs
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
Others
20.29 %
20.29 %
No of Share Holders
20
20

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
09 Jun 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Jun 2026 46.03 44.20

Technical Indicators

RSI(14)
Neutral
41.48
ATR(14)
Less Volatile
1.93
STOCH(9,6)
Neutral
72.75
STOCH RSI(14)
Overbought
87.77
MACD(12,26)
Bullish
0.27
ADX(14)
Weak Trend
17.76
UO(9)
Bearish
57.02
ROC(12)
Uptrend And Accelerating
0.59
WillR(14)
Neutral
-28.90